Quantum dots genosensor for Her2/Neu oncogene - a breast cancer biomarker

Philosophiae Doctor - PhD === The human epidermal growth factor receptor (HER)-family of receptor tyrosine kinases; human epidermal growth factor receptor 1, human epidermal growth factor receptor 2, human epidermal growth factor receptor 3 and human epidermal growth factor receptor 4 (EGFR/HER1, Er...

Full description

Bibliographic Details
Main Author: Fuku, Xolile Godfrey
Other Authors: Baker, Priscilla
Language:en
Published: University of the Western Cape 2015
Subjects:
Online Access:http://hdl.handle.net/11394/4331
id ndltd-netd.ac.za-oai-union.ndltd.org-uwc-oai-etd.uwc.ac.za-11394-4331
record_format oai_dc
spelling ndltd-netd.ac.za-oai-union.ndltd.org-uwc-oai-etd.uwc.ac.za-11394-43312017-08-02T04:00:48Z Quantum dots genosensor for Her2/Neu oncogene - a breast cancer biomarker Fuku, Xolile Godfrey Baker, Priscilla Iwuoha, Emmanuel Biomarkers Chronocoulometry Breast cancer Quantum dots Philosophiae Doctor - PhD The human epidermal growth factor receptor (HER)-family of receptor tyrosine kinases; human epidermal growth factor receptor 1, human epidermal growth factor receptor 2, human epidermal growth factor receptor 3 and human epidermal growth factor receptor 4 (EGFR/HER1, ErbB2/HER2, ErbB3/HER3, and ErbB4/HER4) plays a major role in the pathogenesis of many solid tumours, in approximately 25 - 30% of breast cancers. Breast cancer is the second most common type of cancer and affects around 3000 women annually in South Africa alone. While the benefits of treatment and cancer progress to enhance therapeutic effectiveness for the patient are well documented, it is also important to employ or fabricate methods in which cancer can be screened at an early stage. A number of gene and protein based biomarkers have shown potential in the early screening of cancer. One specific biomarker that is over-expressed in 20 - 30% of human breast cancers is the human epidermal growth factor receptor 2 (Her2/neu). Several methods have been developed for detection of Her2/neu oncogene including immunohistochemistry (IHC), enzyme-linked immunosorbent assay (ELISA), fluorescent in situ hybridisation (FISH) and polymerase chain reaction(PCR). However, these methods are subjected to interference problem. For these reasons an ultrasensitive, cheap and easy to use genosensor has been developed for early detection of the Her2/neu oncogene using electrochemical and spectroscopic methods. Due to their high surface-to-volume ratio, electro-catalytic activity as well as good biocompatibility and novel electron transport properties quantum dots are highly attractive materials for ultra-sensitive detection of biological macromolecules via bio-electronic or bio-optic devices. In this study a quantum dots (QDs)-based genosensor was developed in which Ga2Te3-based quantum dots were synthesised using a novel aqueous solution approach by mixing 3-mercaptopropionic acid (3MPA)-capped gallium metal precursor with reduced tellurium metal. The morphological, compositional and structural characterisation of the QDs was investigated prior to their utilization in DNA sensor construction. 2015-07-28T13:32:34Z 2015-07-28T13:32:34Z 2014 http://hdl.handle.net/11394/4331 en University of the Western Cape University of the Western Cape
collection NDLTD
language en
sources NDLTD
topic Biomarkers
Chronocoulometry
Breast cancer
Quantum dots
spellingShingle Biomarkers
Chronocoulometry
Breast cancer
Quantum dots
Fuku, Xolile Godfrey
Quantum dots genosensor for Her2/Neu oncogene - a breast cancer biomarker
description Philosophiae Doctor - PhD === The human epidermal growth factor receptor (HER)-family of receptor tyrosine kinases; human epidermal growth factor receptor 1, human epidermal growth factor receptor 2, human epidermal growth factor receptor 3 and human epidermal growth factor receptor 4 (EGFR/HER1, ErbB2/HER2, ErbB3/HER3, and ErbB4/HER4) plays a major role in the pathogenesis of many solid tumours, in approximately 25 - 30% of breast cancers. Breast cancer is the second most common type of cancer and affects around 3000 women annually in South Africa alone. While the benefits of treatment and cancer progress to enhance therapeutic effectiveness for the patient are well documented, it is also important to employ or fabricate methods in which cancer can be screened at an early stage. A number of gene and protein based biomarkers have shown potential in the early screening of cancer. One specific biomarker that is over-expressed in 20 - 30% of human breast cancers is the human epidermal growth factor receptor 2 (Her2/neu). Several methods have been developed for detection of Her2/neu oncogene including immunohistochemistry (IHC), enzyme-linked immunosorbent assay (ELISA), fluorescent in situ hybridisation (FISH) and polymerase chain reaction(PCR). However, these methods are subjected to interference problem. For these reasons an ultrasensitive, cheap and easy to use genosensor has been developed for early detection of the Her2/neu oncogene using electrochemical and spectroscopic methods. Due to their high surface-to-volume ratio, electro-catalytic activity as well as good biocompatibility and novel electron transport properties quantum dots are highly attractive materials for ultra-sensitive detection of biological macromolecules via bio-electronic or bio-optic devices. In this study a quantum dots (QDs)-based genosensor was developed in which Ga2Te3-based quantum dots were synthesised using a novel aqueous solution approach by mixing 3-mercaptopropionic acid (3MPA)-capped gallium metal precursor with reduced tellurium metal. The morphological, compositional and structural characterisation of the QDs was investigated prior to their utilization in DNA sensor construction.
author2 Baker, Priscilla
author_facet Baker, Priscilla
Fuku, Xolile Godfrey
author Fuku, Xolile Godfrey
author_sort Fuku, Xolile Godfrey
title Quantum dots genosensor for Her2/Neu oncogene - a breast cancer biomarker
title_short Quantum dots genosensor for Her2/Neu oncogene - a breast cancer biomarker
title_full Quantum dots genosensor for Her2/Neu oncogene - a breast cancer biomarker
title_fullStr Quantum dots genosensor for Her2/Neu oncogene - a breast cancer biomarker
title_full_unstemmed Quantum dots genosensor for Her2/Neu oncogene - a breast cancer biomarker
title_sort quantum dots genosensor for her2/neu oncogene - a breast cancer biomarker
publisher University of the Western Cape
publishDate 2015
url http://hdl.handle.net/11394/4331
work_keys_str_mv AT fukuxolilegodfrey quantumdotsgenosensorforher2neuoncogeneabreastcancerbiomarker
_version_ 1718510938212007936